Fiona Douglas

7.6k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Fiona Douglas is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Fiona Douglas has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Fiona Douglas's work include BRCA gene mutations in cancer (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Global Cancer Incidence and Screening (2 papers). Fiona Douglas is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Global Cancer Incidence and Screening (2 papers). Fiona Douglas collaborates with scholars based in United Kingdom, United States and Netherlands. Fiona Douglas's co-authors include Farida Latif, Patricia L. M. Dahia, Ashraf Dallol, Dewi Astuti, Charis Eng, Emad George, Eamonn R. Maher, Robert Brown, D. Gareth Evans and W. Nicol Keith and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Biochemical Journal.

In The Last Decade

Fiona Douglas

19 papers receiving 1.6k citations

Hit Papers

Gene Mutations in the Succinate Dehydrogenase Subunit SDH... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Douglas United Kingdom 15 748 617 541 427 308 20 1.6k
Shuanzeng Wei United States 20 540 0.7× 326 0.5× 908 1.7× 379 0.9× 504 1.6× 73 2.1k
Marc E. Lippman United States 13 854 1.1× 368 0.6× 792 1.5× 134 0.3× 1.0k 3.3× 16 2.2k
Uziel Beller Israel 25 443 0.6× 411 0.7× 971 1.8× 511 1.2× 723 2.3× 68 3.0k
Treena Cranston United Kingdom 22 146 0.2× 361 0.6× 477 0.9× 209 0.5× 442 1.4× 45 1.8k
Francesca Schiavi Italy 18 882 1.2× 1.1k 1.9× 415 0.8× 1.0k 2.4× 92 0.3× 63 1.8k
Kevin Zbuk Canada 17 245 0.3× 211 0.3× 487 0.9× 119 0.3× 413 1.3× 36 1.3k
June‐Key Chung South Korea 24 242 0.3× 173 0.3× 235 0.4× 253 0.6× 328 1.1× 58 1.4k
Barbara Fowble United States 12 631 0.8× 252 0.4× 126 0.2× 258 0.6× 550 1.8× 19 1.4k
Sergio Rodrı́guez-Cuevas Mexico 16 456 0.6× 244 0.4× 362 0.7× 152 0.4× 238 0.8× 55 929
Koen M.A. Dreijerink Netherlands 25 253 0.3× 301 0.5× 751 1.4× 269 0.6× 669 2.2× 87 2.1k

Countries citing papers authored by Fiona Douglas

Since Specialization
Citations

This map shows the geographic impact of Fiona Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Douglas more than expected).

Fields of papers citing papers by Fiona Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Douglas. The network helps show where Fiona Douglas may publish in the future.

Co-authorship network of co-authors of Fiona Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Douglas. A scholar is included among the top collaborators of Fiona Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Douglas. Fiona Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nieuwenhuis, Marry H., C. Marleen Kets, Maureen Murphy‐Ryan, et al.. (2013). Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome. Familial Cancer. 13(1). 57–63. 91 indexed citations
3.
Nieuwenhuis, Marry H., C. Marleen Kets, Maureen Murphy‐Ryan, et al.. (2012). Is colorectal surveillance indicated in patients with PTEN mutations?. Colorectal Disease. 14(9). e562–6. 25 indexed citations
4.
Zhang, Xiaohua, et al.. (2012). Women's cancers and cancer screening in the Northern Territory. 6 indexed citations
5.
Jones, Elizabeth A., Alison Stewart, Charles Stiller, Fiona Douglas, & Nick Bown. (2011). Wilms tumor incidence in children with 2q terminal deletions: A cohort study. American Journal of Medical Genetics Part A. 155(9). 2221–2223. 3 indexed citations
6.
Douglas, Fiona. (2009). Scottish Newspapers, Language and Identity. Edinburgh University Press eBooks. 15 indexed citations
7.
Henderson, Alex, Fiona Douglas, Petros Perros, Christopher D. Morgan, & Eamonn R. Maher. (2009). SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Familial Cancer. 8(3). 257–260. 38 indexed citations
8.
Douglas, Fiona. (2009). Scottish Newspapers, Language and Identity. Edinburgh University Press eBooks. 6 indexed citations
9.
Andrieu, Nadine, David E. Goldgar, Douglas F. Easton, et al.. (2006). Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI Journal of the National Cancer Institute. 98(8). 535–544. 136 indexed citations
10.
Mitchell, Gillian, Antonis C. Antoniou, Ruth Warren, et al.. (2006). Mammographic Density and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Research. 66(3). 1866–1872. 90 indexed citations
11.
Hopwood, Penelope, David Wonderling, Maggie Watson, et al.. (2004). A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. British Journal of Cancer. 91(5). 884–892. 20 indexed citations
12.
Fraser, Lindsay, C J Chapman, Cherry Chu, et al.. (2003). What motivates interest in attending a familial cancer genetics clinic?. Familial Cancer. 2(3-4). 159–168. 27 indexed citations
13.
Bond, Patricia M., et al.. (2003). Multiple endocrine neoplasia type 2A. Cancer Genetics and Cytogenetics. 141(2). 157–159. 14 indexed citations
14.
Wilson, Colin, et al.. (2003). Gynaecomastia, neurofibromatosis and breast cancer. The Breast. 13(1). 77–79. 18 indexed citations
15.
Wonderling, David, Penelope Hopwood, A. Cull, et al.. (2001). A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. British Journal of Cancer. 85(2). 166–170. 75 indexed citations
16.
Astuti, Dewi, Farida Latif, Ashraf Dallol, et al.. (2001). Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma. The American Journal of Human Genetics. 69(1). 49–54. 840 indexed citations breakdown →
17.
Reid, Evan, Fiona Douglas, Yanick J. Crow, A Hollman, & J C Gibson. (1998). Autosomal dominant juvenile recurrent parotitis.. Journal of Medical Genetics. 35(5). 417–419. 42 indexed citations
18.
Douglas, Fiona, et al.. (1994). Topoisomerase I and II activity in human breast, cervix, lung and colon cancer. International Journal of Cancer. 59(5). 607–611. 73 indexed citations
19.
Keith, W. Nicol, Fiona Douglas, Gordon Wishart, et al.. (1993). Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20. European Journal of Cancer. 29(10). 1469–1475. 60 indexed citations
20.
Nimmo, Hugh G., Fiona Douglas, Colin Kleanthous, David G. Campbell, & Carol MacKintosh. (1989). Identification of a cysteine residue at the active site of Escherichia coli isocitrate lyase. Biochemical Journal. 261(2). 431–435. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026